Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Takihara Y, Inatani M, Fukushima M, Iwao K, Iwao M, Tanihara H . Trabeculectomy with mitomycin C for neovascular glaucoma: prognostic factors for surgical failure. Am J Ophthalmol 2009; 147: 912–918.
Kiuchi Y, Sugimoto R, Nakae K, Saito Y, Ito S . Trabeculectomy with mitomycin C for treatment of neovascular glaucoma in diabetic patients. Ophthalmologica 2006; 220: 383–388.
Miki A, Oshima Y, Otori Y, Kamei M, Tano Y . Efficacy of intravitreal bevacizumab as adjunctive treatment with pars plana vitrectomy, endolaser photocoagulation, and trabeculectomy for neovascular glaucoma. Br J Ophthalmol 2008; 92: 1431–1433.
Kitnarong N, Chindasub P, Metheetrairut A . Surgical outcome of intravitreal bevacizumab and filtration surgery in neovascular glaucoma. Adv Ther 2008; 25: 438–443.
Saito Y, Higashide T, Takeda H, Ohkubo S, Sugiyama K . Beneficial effects of preoperative intravitreal bevacizumab on trabeculectomy outcomes in neovascular glaucoma. Acta Ophthalmol 2009; 23: 23.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Miki, A., Oshima, Y., Otori, Y. et al. One-year results of intravitreal bevacizumab as an adjunct to trabeculectomy for neovascular glaucoma in eyes with previous vitrectomy. Eye 25, 658–659 (2011). https://doi.org/10.1038/eye.2011.58
Published:
Issue date:
DOI: https://doi.org/10.1038/eye.2011.58
